nodes	percent_of_prediction	percent_of_DWPC	metapath
Salmeterol—Salbutamol—asthma	0.203	1	CrCtD
Salmeterol—Adrenergic beta2-Agonists—Indacaterol—asthma	0.072	0.19	CiPCiCtD
Salmeterol—Adrenergic beta2-Agonists—Orciprenaline—asthma	0.072	0.19	CiPCiCtD
Salmeterol—Adrenergic beta2-Agonists—Pirbuterol—asthma	0.072	0.19	CiPCiCtD
Salmeterol—ADRB2—asthma	0.0654	1	CbGaD
Salmeterol—Adrenergic beta2-Agonists—Arformoterol—asthma	0.0546	0.144	CiPCiCtD
Salmeterol—Adrenergic beta2-Agonists—Salbutamol—asthma	0.0546	0.144	CiPCiCtD
Salmeterol—Adrenergic beta2-Agonists—Formoterol—asthma	0.0546	0.144	CiPCiCtD
Salmeterol—Hexoprenaline—Isoprenaline—asthma	0.0249	0.168	CrCrCtD
Salmeterol—Salbutamol—Pirbuterol—asthma	0.0184	0.124	CrCrCtD
Salmeterol—ADRB2—Orciprenaline—asthma	0.0175	0.116	CbGbCtD
Salmeterol—Salbutamol—Terbutaline—asthma	0.015	0.101	CrCrCtD
Salmeterol—Salbutamol—Isoetarine—asthma	0.0144	0.0975	CrCrCtD
Salmeterol—Arbutamine—Arformoterol—asthma	0.0139	0.0939	CrCrCtD
Salmeterol—Arbutamine—Formoterol—asthma	0.0139	0.0939	CrCrCtD
Salmeterol—ADRB2—Terbutaline—asthma	0.0132	0.0877	CbGbCtD
Salmeterol—ADRB2—Isoetarine—asthma	0.0132	0.0877	CbGbCtD
Salmeterol—ADRB2—Pirbuterol—asthma	0.0132	0.0877	CbGbCtD
Salmeterol—Arbutamine—Isoprenaline—asthma	0.0116	0.0784	CrCrCtD
Salmeterol—Salbutamol—Isoprenaline—asthma	0.0109	0.0739	CrCrCtD
Salmeterol—ADRB2—Indacaterol—asthma	0.00918	0.0608	CbGbCtD
Salmeterol—Labetalol—Arformoterol—asthma	0.0088	0.0595	CrCrCtD
Salmeterol—Labetalol—Formoterol—asthma	0.0088	0.0595	CrCrCtD
Salmeterol—ADRB2—Salbutamol—asthma	0.00854	0.0565	CbGbCtD
Salmeterol—Labetalol—Isoprenaline—asthma	0.00734	0.0497	CrCrCtD
Salmeterol—ADRB2—Isoprenaline—asthma	0.00726	0.0481	CbGbCtD
Salmeterol—ADRB2—Formoterol—asthma	0.00647	0.0429	CbGbCtD
Salmeterol—ADRB2—Arformoterol—asthma	0.00647	0.0429	CbGbCtD
Salmeterol—CYP3A7-CYP3A51P—Fluticasone Propionate—asthma	0.00396	0.0262	CbGbCtD
Salmeterol—CYP3A7—Fluticasone Propionate—asthma	0.00396	0.0262	CbGbCtD
Salmeterol—CYP3A5—Beclomethasone—asthma	0.00349	0.0231	CbGbCtD
Salmeterol—CYP2C8—Mometasone—asthma	0.00336	0.0222	CbGbCtD
Salmeterol—CYP3A5—Fluticasone Propionate—asthma	0.00297	0.0197	CbGbCtD
Salmeterol—CYP2C8—Zafirlukast—asthma	0.00263	0.0174	CbGbCtD
Salmeterol—CYP2C8—Theophylline—asthma	0.00203	0.0135	CbGbCtD
Salmeterol—CYP2C8—Loratadine—asthma	0.00193	0.0128	CbGbCtD
Salmeterol—CYP2C8—Montelukast—asthma	0.00193	0.0128	CbGbCtD
Salmeterol—CYP3A4—Fluticasone furoate—asthma	0.0018	0.0119	CbGbCtD
Salmeterol—CYP3A4—Budesonide—asthma	0.0016	0.0106	CbGbCtD
Salmeterol—CYP3A7—Hydrocortisone—asthma	0.00149	0.00985	CbGbCtD
Salmeterol—CYP3A7-CYP3A51P—Hydrocortisone—asthma	0.00149	0.00985	CbGbCtD
Salmeterol—CYP3A4—Ciclesonide—asthma	0.00146	0.0097	CbGbCtD
Salmeterol—CYP3A4—Indacaterol—asthma	0.00146	0.0097	CbGbCtD
Salmeterol—CYP3A4—Flunisolide—asthma	0.00136	0.00902	CbGbCtD
Salmeterol—CYP3A4—Salbutamol—asthma	0.00136	0.00902	CbGbCtD
Salmeterol—CYP3A4—Ipratropium bromide—asthma	0.00121	0.00804	CbGbCtD
Salmeterol—CYP3A4—Zileuton—asthma	0.00121	0.00804	CbGbCtD
Salmeterol—CYP3A4—Fluticasone Propionate—asthma	0.00116	0.00767	CbGbCtD
Salmeterol—CYP3A5—Hydrocortisone—asthma	0.00112	0.00739	CbGbCtD
Salmeterol—CYP2C8—Hydrocortisone—asthma	0.00107	0.0071	CbGbCtD
Salmeterol—CYP3A4—Zafirlukast—asthma	0.00107	0.00708	CbGbCtD
Salmeterol—CYP3A7—Dexamethasone—asthma	0.000925	0.00612	CbGbCtD
Salmeterol—CYP3A7-CYP3A51P—Dexamethasone—asthma	0.000925	0.00612	CbGbCtD
Salmeterol—CYP3A4—Tiotropium—asthma	0.00092	0.00609	CbGbCtD
Salmeterol—CYP3A4—Aminophylline—asthma	0.000877	0.00581	CbGbCtD
Salmeterol—CYP3A4—Theophylline—asthma	0.000825	0.00546	CbGbCtD
Salmeterol—CYP3A4—Loratadine—asthma	0.000782	0.00518	CbGbCtD
Salmeterol—CYP3A4—Montelukast—asthma	0.000782	0.00518	CbGbCtD
Salmeterol—CYP3A4—Methylprednisolone—asthma	0.000715	0.00474	CbGbCtD
Salmeterol—CYP3A5—Dexamethasone—asthma	0.000694	0.00459	CbGbCtD
Salmeterol—CYP2C8—Dexamethasone—asthma	0.000667	0.00442	CbGbCtD
Salmeterol—CYP3A4—Triamcinolone—asthma	0.000542	0.00359	CbGbCtD
Salmeterol—CYP3A4—Betamethasone—asthma	0.000465	0.00308	CbGbCtD
Salmeterol—CYP3A4—Prednisolone—asthma	0.000459	0.00304	CbGbCtD
Salmeterol—CYP3A4—Hydrocortisone—asthma	0.000435	0.00288	CbGbCtD
Salmeterol—CYP3A4—Prednisone—asthma	0.000433	0.00287	CbGbCtD
Salmeterol—CYP3A4—Dexamethasone—asthma	0.00027	0.00179	CbGbCtD
Salmeterol—Arbutamine—ADRB2—asthma	0.000142	0.373	CrCbGaD
Salmeterol—Salbutamol—ADRB2—asthma	0.000138	0.362	CrCbGaD
Salmeterol—Labetalol—ADRB2—asthma	0.000101	0.265	CrCbGaD
Salmeterol—Dermatitis—Formoterol—asthma	7.29e-06	0.000141	CcSEcCtD
Salmeterol—Dermatitis—Arformoterol—asthma	7.29e-06	0.000141	CcSEcCtD
Salmeterol—Headache—Formoterol—asthma	7.25e-06	0.00014	CcSEcCtD
Salmeterol—Headache—Arformoterol—asthma	7.25e-06	0.00014	CcSEcCtD
Salmeterol—Arrhythmia—Triamcinolone—asthma	7.24e-06	0.00014	CcSEcCtD
Salmeterol—Diarrhoea—Budesonide—asthma	7.24e-06	0.00014	CcSEcCtD
Salmeterol—Arrhythmia—Methylprednisolone—asthma	7.23e-06	0.00014	CcSEcCtD
Salmeterol—Dizziness—Salbutamol—asthma	7.22e-06	0.00014	CcSEcCtD
Salmeterol—Hyperglycaemia—Prednisone—asthma	7.22e-06	0.00014	CcSEcCtD
Salmeterol—Vomiting—Montelukast—asthma	7.2e-06	0.00014	CcSEcCtD
Salmeterol—Rash—Montelukast—asthma	7.14e-06	0.000138	CcSEcCtD
Salmeterol—Dermatitis—Montelukast—asthma	7.14e-06	0.000138	CcSEcCtD
Salmeterol—Ill-defined disorder—Prednisolone—asthma	7.12e-06	0.000138	CcSEcCtD
Salmeterol—Headache—Montelukast—asthma	7.1e-06	0.000138	CcSEcCtD
Salmeterol—Mental disorder—Methylprednisolone—asthma	7.09e-06	0.000137	CcSEcCtD
Salmeterol—Malnutrition—Methylprednisolone—asthma	7.04e-06	0.000136	CcSEcCtD
Salmeterol—Angioedema—Prednisolone—asthma	7.01e-06	0.000136	CcSEcCtD
Salmeterol—Dizziness—Budesonide—asthma	7e-06	0.000136	CcSEcCtD
Salmeterol—Ill-defined disorder—Hydrocortisone—asthma	6.96e-06	0.000135	CcSEcCtD
Salmeterol—Vomiting—Salbutamol—asthma	6.95e-06	0.000135	CcSEcCtD
Salmeterol—Malaise—Prednisolone—asthma	6.92e-06	0.000134	CcSEcCtD
Salmeterol—Rash—Salbutamol—asthma	6.89e-06	0.000133	CcSEcCtD
Salmeterol—Dermatitis—Salbutamol—asthma	6.88e-06	0.000133	CcSEcCtD
Salmeterol—Nausea—Formoterol—asthma	6.87e-06	0.000133	CcSEcCtD
Salmeterol—Nausea—Arformoterol—asthma	6.87e-06	0.000133	CcSEcCtD
Salmeterol—Angioedema—Hydrocortisone—asthma	6.85e-06	0.000133	CcSEcCtD
Salmeterol—Headache—Salbutamol—asthma	6.84e-06	0.000133	CcSEcCtD
Salmeterol—Back pain—Triamcinolone—asthma	6.83e-06	0.000132	CcSEcCtD
Salmeterol—Malaise—Hydrocortisone—asthma	6.76e-06	0.000131	CcSEcCtD
Salmeterol—Nausea—Montelukast—asthma	6.73e-06	0.00013	CcSEcCtD
Salmeterol—Vomiting—Budesonide—asthma	6.73e-06	0.00013	CcSEcCtD
Salmeterol—Rash—Budesonide—asthma	6.67e-06	0.000129	CcSEcCtD
Salmeterol—Dermatitis—Budesonide—asthma	6.67e-06	0.000129	CcSEcCtD
Salmeterol—Headache—Budesonide—asthma	6.63e-06	0.000128	CcSEcCtD
Salmeterol—Hypertension—Prednisolone—asthma	6.63e-06	0.000128	CcSEcCtD
Salmeterol—Arrhythmia—Dexamethasone—asthma	6.57e-06	0.000127	CcSEcCtD
Salmeterol—Arrhythmia—Betamethasone—asthma	6.57e-06	0.000127	CcSEcCtD
Salmeterol—Ill-defined disorder—Triamcinolone—asthma	6.55e-06	0.000127	CcSEcCtD
Salmeterol—Ill-defined disorder—Methylprednisolone—asthma	6.54e-06	0.000127	CcSEcCtD
Salmeterol—Nausea—Salbutamol—asthma	6.49e-06	0.000126	CcSEcCtD
Salmeterol—Hypertension—Hydrocortisone—asthma	6.47e-06	0.000125	CcSEcCtD
Salmeterol—Discomfort—Prednisolone—asthma	6.46e-06	0.000125	CcSEcCtD
Salmeterol—Angioedema—Triamcinolone—asthma	6.45e-06	0.000125	CcSEcCtD
Salmeterol—Angioedema—Methylprednisolone—asthma	6.44e-06	0.000125	CcSEcCtD
Salmeterol—Myalgia—Hydrocortisone—asthma	6.38e-06	0.000124	CcSEcCtD
Salmeterol—Malaise—Triamcinolone—asthma	6.37e-06	0.000123	CcSEcCtD
Salmeterol—Anxiety—Hydrocortisone—asthma	6.36e-06	0.000123	CcSEcCtD
Salmeterol—Malaise—Methylprednisolone—asthma	6.35e-06	0.000123	CcSEcCtD
Salmeterol—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—asthma	6.34e-06	0.000123	CcSEcCtD
Salmeterol—Discomfort—Hydrocortisone—asthma	6.31e-06	0.000122	CcSEcCtD
Salmeterol—Connective tissue disorder—Prednisone—asthma	6.3e-06	0.000122	CcSEcCtD
Salmeterol—Nausea—Budesonide—asthma	6.29e-06	0.000122	CcSEcCtD
Salmeterol—Oedema—Prednisolone—asthma	6.27e-06	0.000121	CcSEcCtD
Salmeterol—Anaphylactic shock—Prednisolone—asthma	6.27e-06	0.000121	CcSEcCtD
Salmeterol—Cough—Triamcinolone—asthma	6.16e-06	0.000119	CcSEcCtD
Salmeterol—Oedema—Hydrocortisone—asthma	6.12e-06	0.000119	CcSEcCtD
Salmeterol—Anaphylactic shock—Hydrocortisone—asthma	6.12e-06	0.000119	CcSEcCtD
Salmeterol—Tachycardia—Prednisolone—asthma	6.11e-06	0.000118	CcSEcCtD
Salmeterol—Hypertension—Triamcinolone—asthma	6.1e-06	0.000118	CcSEcCtD
Salmeterol—Hypertension—Methylprednisolone—asthma	6.08e-06	0.000118	CcSEcCtD
Salmeterol—Infection—Hydrocortisone—asthma	6.08e-06	0.000118	CcSEcCtD
Salmeterol—Myalgia—Triamcinolone—asthma	6.01e-06	0.000116	CcSEcCtD
Salmeterol—Nervous system disorder—Hydrocortisone—asthma	6e-06	0.000116	CcSEcCtD
Salmeterol—Arthralgia—Methylprednisolone—asthma	6e-06	0.000116	CcSEcCtD
Salmeterol—Myalgia—Methylprednisolone—asthma	6e-06	0.000116	CcSEcCtD
Salmeterol—Anxiety—Methylprednisolone—asthma	5.98e-06	0.000116	CcSEcCtD
Salmeterol—Tachycardia—Hydrocortisone—asthma	5.97e-06	0.000116	CcSEcCtD
Salmeterol—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—asthma	5.96e-06	0.000115	CcSEcCtD
Salmeterol—Skin disorder—Hydrocortisone—asthma	5.94e-06	0.000115	CcSEcCtD
Salmeterol—Ill-defined disorder—Dexamethasone—asthma	5.94e-06	0.000115	CcSEcCtD
Salmeterol—Ill-defined disorder—Betamethasone—asthma	5.94e-06	0.000115	CcSEcCtD
Salmeterol—Discomfort—Triamcinolone—asthma	5.94e-06	0.000115	CcSEcCtD
Salmeterol—Discomfort—Methylprednisolone—asthma	5.93e-06	0.000115	CcSEcCtD
Salmeterol—Dry mouth—Triamcinolone—asthma	5.88e-06	0.000114	CcSEcCtD
Salmeterol—Angioedema—Betamethasone—asthma	5.85e-06	0.000113	CcSEcCtD
Salmeterol—Angioedema—Dexamethasone—asthma	5.85e-06	0.000113	CcSEcCtD
Salmeterol—Immune system disorder—Prednisone—asthma	5.79e-06	0.000112	CcSEcCtD
Salmeterol—Malaise—Betamethasone—asthma	5.78e-06	0.000112	CcSEcCtD
Salmeterol—Malaise—Dexamethasone—asthma	5.78e-06	0.000112	CcSEcCtD
Salmeterol—Anaphylactic shock—Triamcinolone—asthma	5.76e-06	0.000112	CcSEcCtD
Salmeterol—Oedema—Triamcinolone—asthma	5.76e-06	0.000112	CcSEcCtD
Salmeterol—Anaphylactic shock—Methylprednisolone—asthma	5.75e-06	0.000111	CcSEcCtD
Salmeterol—Arrhythmia—Prednisone—asthma	5.72e-06	0.000111	CcSEcCtD
Salmeterol—Infection—Triamcinolone—asthma	5.72e-06	0.000111	CcSEcCtD
Salmeterol—Infection—Methylprednisolone—asthma	5.71e-06	0.000111	CcSEcCtD
Salmeterol—Insomnia—Prednisolone—asthma	5.67e-06	0.00011	CcSEcCtD
Salmeterol—Nervous system disorder—Methylprednisolone—asthma	5.64e-06	0.000109	CcSEcCtD
Salmeterol—Paraesthesia—Prednisolone—asthma	5.63e-06	0.000109	CcSEcCtD
Salmeterol—Tachycardia—Triamcinolone—asthma	5.62e-06	0.000109	CcSEcCtD
Salmeterol—Mental disorder—Prednisone—asthma	5.61e-06	0.000109	CcSEcCtD
Salmeterol—Tachycardia—Methylprednisolone—asthma	5.61e-06	0.000109	CcSEcCtD
Salmeterol—Skin disorder—Methylprednisolone—asthma	5.58e-06	0.000108	CcSEcCtD
Salmeterol—Malnutrition—Prednisone—asthma	5.58e-06	0.000108	CcSEcCtD
Salmeterol—Musculoskeletal discomfort—Hydrocortisone—asthma	5.58e-06	0.000108	CcSEcCtD
Salmeterol—Insomnia—Hydrocortisone—asthma	5.53e-06	0.000107	CcSEcCtD
Salmeterol—Hypertension—Dexamethasone—asthma	5.53e-06	0.000107	CcSEcCtD
Salmeterol—Hypertension—Betamethasone—asthma	5.53e-06	0.000107	CcSEcCtD
Salmeterol—Paraesthesia—Hydrocortisone—asthma	5.49e-06	0.000106	CcSEcCtD
Salmeterol—Myalgia—Dexamethasone—asthma	5.45e-06	0.000106	CcSEcCtD
Salmeterol—Myalgia—Betamethasone—asthma	5.45e-06	0.000106	CcSEcCtD
Salmeterol—Anxiety—Betamethasone—asthma	5.43e-06	0.000105	CcSEcCtD
Salmeterol—Anxiety—Dexamethasone—asthma	5.43e-06	0.000105	CcSEcCtD
Salmeterol—Discomfort—Dexamethasone—asthma	5.39e-06	0.000104	CcSEcCtD
Salmeterol—Discomfort—Betamethasone—asthma	5.39e-06	0.000104	CcSEcCtD
Salmeterol—Dyspepsia—Hydrocortisone—asthma	5.39e-06	0.000104	CcSEcCtD
Salmeterol—Pain—Prednisolone—asthma	5.36e-06	0.000104	CcSEcCtD
Salmeterol—Fatigue—Hydrocortisone—asthma	5.28e-06	0.000102	CcSEcCtD
Salmeterol—Musculoskeletal discomfort—Triamcinolone—asthma	5.25e-06	0.000102	CcSEcCtD
Salmeterol—Musculoskeletal discomfort—Methylprednisolone—asthma	5.24e-06	0.000101	CcSEcCtD
Salmeterol—Pain—Hydrocortisone—asthma	5.23e-06	0.000101	CcSEcCtD
Salmeterol—Anaphylactic shock—Betamethasone—asthma	5.23e-06	0.000101	CcSEcCtD
Salmeterol—Oedema—Dexamethasone—asthma	5.23e-06	0.000101	CcSEcCtD
Salmeterol—Anaphylactic shock—Dexamethasone—asthma	5.23e-06	0.000101	CcSEcCtD
Salmeterol—Oedema—Betamethasone—asthma	5.23e-06	0.000101	CcSEcCtD
Salmeterol—Insomnia—Triamcinolone—asthma	5.21e-06	0.000101	CcSEcCtD
Salmeterol—Insomnia—Methylprednisolone—asthma	5.2e-06	0.000101	CcSEcCtD
Salmeterol—Infection—Dexamethasone—asthma	5.19e-06	0.000101	CcSEcCtD
Salmeterol—Infection—Betamethasone—asthma	5.19e-06	0.000101	CcSEcCtD
Salmeterol—Ill-defined disorder—Prednisone—asthma	5.18e-06	0.0001	CcSEcCtD
Salmeterol—Paraesthesia—Triamcinolone—asthma	5.17e-06	0.0001	CcSEcCtD
Salmeterol—Feeling abnormal—Prednisolone—asthma	5.16e-06	0.0001	CcSEcCtD
Salmeterol—Paraesthesia—Methylprednisolone—asthma	5.16e-06	0.0001	CcSEcCtD
Salmeterol—Dyspnoea—Triamcinolone—asthma	5.14e-06	9.95e-05	CcSEcCtD
Salmeterol—Nervous system disorder—Betamethasone—asthma	5.13e-06	9.93e-05	CcSEcCtD
Salmeterol—Nervous system disorder—Dexamethasone—asthma	5.13e-06	9.93e-05	CcSEcCtD
Salmeterol—Agitation—Prednisone—asthma	5.13e-06	9.93e-05	CcSEcCtD
Salmeterol—Tachycardia—Betamethasone—asthma	5.1e-06	9.88e-05	CcSEcCtD
Salmeterol—Tachycardia—Dexamethasone—asthma	5.1e-06	9.88e-05	CcSEcCtD
Salmeterol—Angioedema—Prednisone—asthma	5.1e-06	9.88e-05	CcSEcCtD
Salmeterol—Dyspepsia—Triamcinolone—asthma	5.07e-06	9.83e-05	CcSEcCtD
Salmeterol—Dyspepsia—Methylprednisolone—asthma	5.06e-06	9.8e-05	CcSEcCtD
Salmeterol—Feeling abnormal—Hydrocortisone—asthma	5.04e-06	9.77e-05	CcSEcCtD
Salmeterol—Malaise—Prednisone—asthma	5.03e-06	9.75e-05	CcSEcCtD
Salmeterol—Gastrointestinal pain—Hydrocortisone—asthma	5e-06	9.69e-05	CcSEcCtD
Salmeterol—Urticaria—Prednisolone—asthma	4.98e-06	9.64e-05	CcSEcCtD
Salmeterol—Fatigue—Triamcinolone—asthma	4.97e-06	9.62e-05	CcSEcCtD
Salmeterol—Fatigue—Methylprednisolone—asthma	4.96e-06	9.6e-05	CcSEcCtD
Salmeterol—Pain—Triamcinolone—asthma	4.93e-06	9.55e-05	CcSEcCtD
Salmeterol—Urticaria—Hydrocortisone—asthma	4.86e-06	9.42e-05	CcSEcCtD
Salmeterol—Abdominal pain—Hydrocortisone—asthma	4.84e-06	9.37e-05	CcSEcCtD
Salmeterol—Body temperature increased—Hydrocortisone—asthma	4.84e-06	9.37e-05	CcSEcCtD
Salmeterol—Hypertension—Prednisone—asthma	4.82e-06	9.33e-05	CcSEcCtD
Salmeterol—Musculoskeletal discomfort—Dexamethasone—asthma	4.76e-06	9.23e-05	CcSEcCtD
Salmeterol—Musculoskeletal discomfort—Betamethasone—asthma	4.76e-06	9.23e-05	CcSEcCtD
Salmeterol—Myalgia—Prednisone—asthma	4.75e-06	9.2e-05	CcSEcCtD
Salmeterol—Arthralgia—Prednisone—asthma	4.75e-06	9.2e-05	CcSEcCtD
Salmeterol—Feeling abnormal—Triamcinolone—asthma	4.75e-06	9.2e-05	CcSEcCtD
Salmeterol—Feeling abnormal—Methylprednisolone—asthma	4.74e-06	9.18e-05	CcSEcCtD
Salmeterol—Anxiety—Prednisone—asthma	4.73e-06	9.17e-05	CcSEcCtD
Salmeterol—Insomnia—Betamethasone—asthma	4.73e-06	9.16e-05	CcSEcCtD
Salmeterol—Insomnia—Dexamethasone—asthma	4.73e-06	9.16e-05	CcSEcCtD
Salmeterol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—asthma	4.72e-06	9.14e-05	CcSEcCtD
Salmeterol—Gastrointestinal pain—Methylprednisolone—asthma	4.7e-06	9.11e-05	CcSEcCtD
Salmeterol—Paraesthesia—Betamethasone—asthma	4.69e-06	9.09e-05	CcSEcCtD
Salmeterol—Paraesthesia—Dexamethasone—asthma	4.69e-06	9.09e-05	CcSEcCtD
Salmeterol—Discomfort—Prednisone—asthma	4.69e-06	9.09e-05	CcSEcCtD
Salmeterol—Hypersensitivity—Prednisolone—asthma	4.62e-06	8.94e-05	CcSEcCtD
Salmeterol—Dyspepsia—Dexamethasone—asthma	4.6e-06	8.92e-05	CcSEcCtD
Salmeterol—Dyspepsia—Betamethasone—asthma	4.6e-06	8.92e-05	CcSEcCtD
Salmeterol—Urticaria—Triamcinolone—asthma	4.58e-06	8.87e-05	CcSEcCtD
Salmeterol—Urticaria—Methylprednisolone—asthma	4.57e-06	8.85e-05	CcSEcCtD
Salmeterol—Body temperature increased—Triamcinolone—asthma	4.55e-06	8.82e-05	CcSEcCtD
Salmeterol—Anaphylactic shock—Prednisone—asthma	4.55e-06	8.82e-05	CcSEcCtD
Salmeterol—Oedema—Prednisone—asthma	4.55e-06	8.82e-05	CcSEcCtD
Salmeterol—Abdominal pain—Methylprednisolone—asthma	4.54e-06	8.8e-05	CcSEcCtD
Salmeterol—Infection—Prednisone—asthma	4.52e-06	8.76e-05	CcSEcCtD
Salmeterol—Hypersensitivity—Hydrocortisone—asthma	4.51e-06	8.73e-05	CcSEcCtD
Salmeterol—Fatigue—Dexamethasone—asthma	4.51e-06	8.73e-05	CcSEcCtD
Salmeterol—Fatigue—Betamethasone—asthma	4.51e-06	8.73e-05	CcSEcCtD
Salmeterol—Pain—Betamethasone—asthma	4.47e-06	8.66e-05	CcSEcCtD
Salmeterol—Pain—Dexamethasone—asthma	4.47e-06	8.66e-05	CcSEcCtD
Salmeterol—Nervous system disorder—Prednisone—asthma	4.46e-06	8.65e-05	CcSEcCtD
Salmeterol—Tachycardia—Prednisone—asthma	4.44e-06	8.61e-05	CcSEcCtD
Salmeterol—Skin disorder—Prednisone—asthma	4.42e-06	8.57e-05	CcSEcCtD
Salmeterol—Asthenia—Hydrocortisone—asthma	4.39e-06	8.51e-05	CcSEcCtD
Salmeterol—Feeling abnormal—Dexamethasone—asthma	4.31e-06	8.35e-05	CcSEcCtD
Salmeterol—Feeling abnormal—Betamethasone—asthma	4.31e-06	8.35e-05	CcSEcCtD
Salmeterol—Gastrointestinal pain—Dexamethasone—asthma	4.28e-06	8.28e-05	CcSEcCtD
Salmeterol—Gastrointestinal pain—Betamethasone—asthma	4.28e-06	8.28e-05	CcSEcCtD
Salmeterol—Hypersensitivity—Triamcinolone—asthma	4.25e-06	8.22e-05	CcSEcCtD
Salmeterol—Hypersensitivity—Methylprednisolone—asthma	4.24e-06	8.21e-05	CcSEcCtD
Salmeterol—Diarrhoea—Hydrocortisone—asthma	4.19e-06	8.11e-05	CcSEcCtD
Salmeterol—Urticaria—Betamethasone—asthma	4.15e-06	8.05e-05	CcSEcCtD
Salmeterol—Urticaria—Dexamethasone—asthma	4.15e-06	8.05e-05	CcSEcCtD
Salmeterol—Musculoskeletal discomfort—Prednisone—asthma	4.15e-06	8.04e-05	CcSEcCtD
Salmeterol—Dizziness—Prednisolone—asthma	4.14e-06	8.03e-05	CcSEcCtD
Salmeterol—Asthenia—Triamcinolone—asthma	4.13e-06	8.01e-05	CcSEcCtD
Salmeterol—Abdominal pain—Dexamethasone—asthma	4.13e-06	8.01e-05	CcSEcCtD
Salmeterol—Body temperature increased—Dexamethasone—asthma	4.13e-06	8.01e-05	CcSEcCtD
Salmeterol—Abdominal pain—Betamethasone—asthma	4.13e-06	8.01e-05	CcSEcCtD
Salmeterol—Body temperature increased—Betamethasone—asthma	4.13e-06	8.01e-05	CcSEcCtD
Salmeterol—Asthenia—Methylprednisolone—asthma	4.12e-06	7.99e-05	CcSEcCtD
Salmeterol—Insomnia—Prednisone—asthma	4.12e-06	7.98e-05	CcSEcCtD
Salmeterol—Paraesthesia—Prednisone—asthma	4.09e-06	7.92e-05	CcSEcCtD
Salmeterol—Dizziness—Hydrocortisone—asthma	4.05e-06	7.84e-05	CcSEcCtD
Salmeterol—Dyspepsia—Prednisone—asthma	4.01e-06	7.76e-05	CcSEcCtD
Salmeterol—Rash—Prednisolone—asthma	3.95e-06	7.65e-05	CcSEcCtD
Salmeterol—Dermatitis—Prednisolone—asthma	3.95e-06	7.65e-05	CcSEcCtD
Salmeterol—Diarrhoea—Methylprednisolone—asthma	3.93e-06	7.62e-05	CcSEcCtD
Salmeterol—Fatigue—Prednisone—asthma	3.93e-06	7.6e-05	CcSEcCtD
Salmeterol—Headache—Prednisolone—asthma	3.93e-06	7.6e-05	CcSEcCtD
Salmeterol—Constipation—Prednisone—asthma	3.89e-06	7.54e-05	CcSEcCtD
Salmeterol—Vomiting—Hydrocortisone—asthma	3.89e-06	7.54e-05	CcSEcCtD
Salmeterol—Rash—Hydrocortisone—asthma	3.86e-06	7.47e-05	CcSEcCtD
Salmeterol—Dermatitis—Hydrocortisone—asthma	3.85e-06	7.47e-05	CcSEcCtD
Salmeterol—Headache—Hydrocortisone—asthma	3.83e-06	7.43e-05	CcSEcCtD
Salmeterol—Dizziness—Triamcinolone—asthma	3.81e-06	7.38e-05	CcSEcCtD
Salmeterol—Dizziness—Methylprednisolone—asthma	3.8e-06	7.36e-05	CcSEcCtD
Salmeterol—Feeling abnormal—Prednisone—asthma	3.75e-06	7.27e-05	CcSEcCtD
Salmeterol—Asthenia—Betamethasone—asthma	3.75e-06	7.27e-05	CcSEcCtD
Salmeterol—Asthenia—Dexamethasone—asthma	3.75e-06	7.27e-05	CcSEcCtD
Salmeterol—Gastrointestinal pain—Prednisone—asthma	3.72e-06	7.21e-05	CcSEcCtD
Salmeterol—Nausea—Prednisolone—asthma	3.72e-06	7.21e-05	CcSEcCtD
Salmeterol—Vomiting—Triamcinolone—asthma	3.66e-06	7.1e-05	CcSEcCtD
Salmeterol—Vomiting—Methylprednisolone—asthma	3.66e-06	7.08e-05	CcSEcCtD
Salmeterol—Nausea—Hydrocortisone—asthma	3.63e-06	7.04e-05	CcSEcCtD
Salmeterol—Rash—Triamcinolone—asthma	3.63e-06	7.04e-05	CcSEcCtD
Salmeterol—Dermatitis—Triamcinolone—asthma	3.63e-06	7.03e-05	CcSEcCtD
Salmeterol—Rash—Methylprednisolone—asthma	3.62e-06	7.02e-05	CcSEcCtD
Salmeterol—Dermatitis—Methylprednisolone—asthma	3.62e-06	7.02e-05	CcSEcCtD
Salmeterol—Urticaria—Prednisone—asthma	3.62e-06	7.01e-05	CcSEcCtD
Salmeterol—Headache—Triamcinolone—asthma	3.61e-06	6.99e-05	CcSEcCtD
Salmeterol—Headache—Methylprednisolone—asthma	3.6e-06	6.98e-05	CcSEcCtD
Salmeterol—Abdominal pain—Prednisone—asthma	3.6e-06	6.97e-05	CcSEcCtD
Salmeterol—Body temperature increased—Prednisone—asthma	3.6e-06	6.97e-05	CcSEcCtD
Salmeterol—Diarrhoea—Betamethasone—asthma	3.58e-06	6.93e-05	CcSEcCtD
Salmeterol—Diarrhoea—Dexamethasone—asthma	3.58e-06	6.93e-05	CcSEcCtD
Salmeterol—Dizziness—Dexamethasone—asthma	3.46e-06	6.7e-05	CcSEcCtD
Salmeterol—Dizziness—Betamethasone—asthma	3.46e-06	6.7e-05	CcSEcCtD
Salmeterol—Nausea—Triamcinolone—asthma	3.42e-06	6.63e-05	CcSEcCtD
Salmeterol—Nausea—Methylprednisolone—asthma	3.41e-06	6.62e-05	CcSEcCtD
Salmeterol—Hypersensitivity—Prednisone—asthma	3.35e-06	6.5e-05	CcSEcCtD
Salmeterol—Vomiting—Dexamethasone—asthma	3.32e-06	6.44e-05	CcSEcCtD
Salmeterol—Vomiting—Betamethasone—asthma	3.32e-06	6.44e-05	CcSEcCtD
Salmeterol—Rash—Betamethasone—asthma	3.3e-06	6.39e-05	CcSEcCtD
Salmeterol—Rash—Dexamethasone—asthma	3.3e-06	6.39e-05	CcSEcCtD
Salmeterol—Dermatitis—Dexamethasone—asthma	3.29e-06	6.38e-05	CcSEcCtD
Salmeterol—Dermatitis—Betamethasone—asthma	3.29e-06	6.38e-05	CcSEcCtD
Salmeterol—Headache—Dexamethasone—asthma	3.28e-06	6.34e-05	CcSEcCtD
Salmeterol—Headache—Betamethasone—asthma	3.28e-06	6.34e-05	CcSEcCtD
Salmeterol—Asthenia—Prednisone—asthma	3.27e-06	6.33e-05	CcSEcCtD
Salmeterol—Diarrhoea—Prednisone—asthma	3.12e-06	6.03e-05	CcSEcCtD
Salmeterol—Nausea—Dexamethasone—asthma	3.11e-06	6.02e-05	CcSEcCtD
Salmeterol—Nausea—Betamethasone—asthma	3.11e-06	6.02e-05	CcSEcCtD
Salmeterol—Dizziness—Prednisone—asthma	3.01e-06	5.83e-05	CcSEcCtD
Salmeterol—Vomiting—Prednisone—asthma	2.89e-06	5.61e-05	CcSEcCtD
Salmeterol—Rash—Prednisone—asthma	2.87e-06	5.56e-05	CcSEcCtD
Salmeterol—Dermatitis—Prednisone—asthma	2.87e-06	5.56e-05	CcSEcCtD
Salmeterol—Headache—Prednisone—asthma	2.85e-06	5.53e-05	CcSEcCtD
Salmeterol—Nausea—Prednisone—asthma	2.7e-06	5.24e-05	CcSEcCtD
Salmeterol—ADRB2—Signaling by GPCR—C5—asthma	1.47e-06	0.00127	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—TACR1—asthma	1.47e-06	0.00127	CbGpPWpGaD
Salmeterol—CYP3A4—Phase 1 - Functionalization of compounds—POMC—asthma	1.46e-06	0.00127	CbGpPWpGaD
Salmeterol—CYP2C8—Biological oxidations—POMC—asthma	1.45e-06	0.00126	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—NPY—asthma	1.44e-06	0.00125	CbGpPWpGaD
Salmeterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL2—asthma	1.44e-06	0.00125	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—ARG2—asthma	1.43e-06	0.00124	CbGpPWpGaD
Salmeterol—ADRB2—GPCR ligand binding—CCR5—asthma	1.43e-06	0.00124	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—ALOX5—asthma	1.42e-06	0.00123	CbGpPWpGaD
Salmeterol—ADRB2—GPCR ligand binding—C3—asthma	1.4e-06	0.00122	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—AGTR2—asthma	1.39e-06	0.00121	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—LTA4H—asthma	1.37e-06	0.00119	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—LTC4S—asthma	1.37e-06	0.00119	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—CARM1—asthma	1.35e-06	0.00118	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—CCR3—asthma	1.34e-06	0.00116	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—EDNRB—asthma	1.33e-06	0.00115	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—NPS—asthma	1.32e-06	0.00114	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—TAC1—asthma	1.32e-06	0.00114	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—NPY—asthma	1.31e-06	0.00113	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—CXCR3—asthma	1.29e-06	0.00112	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—NPSR1—asthma	1.28e-06	0.00111	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—PTGDR2—asthma	1.28e-06	0.00111	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—HRH4—asthma	1.28e-06	0.00111	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—PMCH—asthma	1.28e-06	0.00111	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—AGTR2—asthma	1.26e-06	0.00109	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—CSF2RB—asthma	1.26e-06	0.00109	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—TACR2—asthma	1.23e-06	0.00107	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—CCR8—asthma	1.23e-06	0.00107	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—IL5—asthma	1.22e-06	0.00106	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—EDNRB—asthma	1.21e-06	0.00105	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—CCL17—asthma	1.21e-06	0.00105	CbGpPWpGaD
Salmeterol—CYP3A4—Biological oxidations—GSTP1—asthma	1.2e-06	0.00104	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—TAC1—asthma	1.2e-06	0.00104	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—NPS—asthma	1.2e-06	0.00104	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—ARG1—asthma	1.19e-06	0.00104	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—ALOX5AP—asthma	1.19e-06	0.00103	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—ALOX15—asthma	1.19e-06	0.00103	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—LTA4H—asthma	1.18e-06	0.00103	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—BDKRB2—asthma	1.18e-06	0.00103	CbGpPWpGaD
Salmeterol—CYP3A4—Metapathway biotransformation—GSTP1—asthma	1.18e-06	0.00102	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—CXCR3—asthma	1.17e-06	0.00102	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—ADCY2—asthma	1.14e-06	0.000992	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—IL3—asthma	1.14e-06	0.000989	CbGpPWpGaD
Salmeterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—asthma	1.14e-06	0.000987	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—CHAT—asthma	1.13e-06	0.000983	CbGpPWpGaD
Salmeterol—ADRB2—GPCR ligand binding—POMC—asthma	1.12e-06	0.000972	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—IL5—asthma	1.11e-06	0.000965	CbGpPWpGaD
Salmeterol—CYP3A4—Biological oxidations—GSTM1—asthma	1.1e-06	0.000954	CbGpPWpGaD
Salmeterol—ADRB2—GPCR ligand binding—CCL2—asthma	1.1e-06	0.000951	CbGpPWpGaD
Salmeterol—CYP3A4—Metapathway biotransformation—GSTM1—asthma	1.08e-06	0.000941	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—ALDH7A1—asthma	1.08e-06	0.000938	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—PDE4A—asthma	1.08e-06	0.000933	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—KIF3A—asthma	1.08e-06	0.000933	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—KNG1—asthma	1.07e-06	0.000933	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—BDKRB2—asthma	1.07e-06	0.000931	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—AGTR1—asthma	1.07e-06	0.000927	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—CXCL10—asthma	1.04e-06	0.000906	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—ADCY2—asthma	1.04e-06	0.000901	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—ARG2—asthma	1.04e-06	0.000899	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—ARG1—asthma	1.03e-06	0.000898	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—IL3—asthma	1.03e-06	0.000898	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—ALOX5—asthma	1.01e-06	0.000876	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—CYSLTR1—asthma	1.01e-06	0.000874	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—KNG1—asthma	9.76e-07	0.000847	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—C5AR1—asthma	9.72e-07	0.000844	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—UTS2—asthma	9.72e-07	0.000844	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—VIP—asthma	9.72e-07	0.000844	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—CCL11—asthma	9.72e-07	0.000844	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—CMA1—asthma	9.72e-07	0.000844	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—AGTR1—asthma	9.7e-07	0.000842	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—CARM1—asthma	9.63e-07	0.000836	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—ITPR1—asthma	9.58e-07	0.000832	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—DCN—asthma	9.49e-07	0.000824	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—CXCL10—asthma	9.48e-07	0.000823	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—ALDH7A1—asthma	9.36e-07	0.000812	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—CCR4—asthma	9.32e-07	0.000809	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—ALDH2—asthma	9.23e-07	0.000802	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—STAT6—asthma	9.14e-07	0.000793	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—EDN1—asthma	9.06e-07	0.000786	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—CCL5—asthma	8.99e-07	0.00078	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—ARG2—asthma	8.97e-07	0.000779	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—IL2RB—asthma	8.97e-07	0.000779	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—PDE4D—asthma	8.89e-07	0.000772	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—CSF2—asthma	8.85e-07	0.000768	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—GSTT1—asthma	8.78e-07	0.000762	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—ITPR1—asthma	8.7e-07	0.000756	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—PDE4B—asthma	8.67e-07	0.000752	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—C5—asthma	8.67e-07	0.000752	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—TACR1—asthma	8.67e-07	0.000752	CbGpPWpGaD
Salmeterol—ADRB2—GPCR ligand binding—CXCL8—asthma	8.66e-07	0.000752	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—ALOX15—asthma	8.58e-07	0.000745	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—ALOX5AP—asthma	8.58e-07	0.000745	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—EDN1—asthma	8.22e-07	0.000714	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—CHAT—asthma	8.19e-07	0.000711	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—CCL5—asthma	8.16e-07	0.000708	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—PLA2G4A—asthma	8.13e-07	0.000706	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—CCR5—asthma	8.1e-07	0.000703	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—CSF2—asthma	8.04e-07	0.000698	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—IL2RA—asthma	7.98e-07	0.000693	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—CCR3—asthma	7.93e-07	0.000688	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—C3—asthma	7.91e-07	0.000687	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—asthma	7.87e-07	0.000683	CbGpPWpGaD
Salmeterol—CYP3A4—Biological oxidations—POMC—asthma	7.77e-07	0.000675	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—NPY—asthma	7.72e-07	0.00067	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—PPP2CA—asthma	7.49e-07	0.00065	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—AGTR2—asthma	7.45e-07	0.000647	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—ALOX5AP—asthma	7.43e-07	0.000645	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—ALOX15—asthma	7.43e-07	0.000645	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—CCR5—asthma	7.35e-07	0.000638	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—LTC4S—asthma	7.33e-07	0.000636	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—NQO1—asthma	7.3e-07	0.000634	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—ALOX5—asthma	7.3e-07	0.000634	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—IL2RA—asthma	7.25e-07	0.000629	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—C3—asthma	7.18e-07	0.000624	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—ADCY2—asthma	7.14e-07	0.00062	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—EDNRB—asthma	7.14e-07	0.000619	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—CHAT—asthma	7.09e-07	0.000616	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—TAC1—asthma	7.06e-07	0.000613	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—NPS—asthma	7.06e-07	0.000613	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—CARM1—asthma	6.96e-07	0.000604	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—CXCR3—asthma	6.93e-07	0.000601	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—DCN—asthma	6.86e-07	0.000596	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—CYBA—asthma	6.71e-07	0.000582	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—ALDH2—asthma	6.68e-07	0.000579	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—IL5—asthma	6.57e-07	0.00057	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—PARP1—asthma	6.57e-07	0.00057	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—LTA4H—asthma	6.35e-07	0.000552	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—GSTT1—asthma	6.35e-07	0.000551	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—BDKRB2—asthma	6.34e-07	0.00055	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—POMC—asthma	6.33e-07	0.000549	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—ALOX5—asthma	6.32e-07	0.000549	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—ADCY2—asthma	6.13e-07	0.000532	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—IL3—asthma	6.11e-07	0.00053	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—GSTP1—asthma	6.09e-07	0.000529	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—CARM1—asthma	6.03e-07	0.000524	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—HMOX1—asthma	6e-07	0.000521	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—ITPR1—asthma	5.99e-07	0.00052	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—DCN—asthma	5.94e-07	0.000516	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—CAT—asthma	5.92e-07	0.000514	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—ALDH2—asthma	5.78e-07	0.000502	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—KNG1—asthma	5.76e-07	0.0005	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—POMC—asthma	5.75e-07	0.000499	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—AGTR1—asthma	5.73e-07	0.000497	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—CCL2—asthma	5.62e-07	0.000488	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—IL6R—asthma	5.6e-07	0.000487	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—CXCL10—asthma	5.6e-07	0.000486	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—GSTM1—asthma	5.6e-07	0.000486	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—PLA2G4A—asthma	5.6e-07	0.000486	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—RHOA—asthma	5.58e-07	0.000484	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—POMC—asthma	5.56e-07	0.000483	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—ARG1—asthma	5.55e-07	0.000482	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—GSTT1—asthma	5.5e-07	0.000477	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—NTRK1—asthma	5.49e-07	0.000477	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—NQO1—asthma	5.28e-07	0.000458	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—ADCY2—asthma	5.16e-07	0.000448	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—PPP2CA—asthma	5.15e-07	0.000447	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—ITPR1—asthma	5.14e-07	0.000446	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—ALB—asthma	5.07e-07	0.00044	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—RHOA—asthma	5.06e-07	0.000439	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—ALDH7A1—asthma	5.02e-07	0.000436	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—CD86—asthma	4.9e-07	0.000425	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—CXCL8—asthma	4.89e-07	0.000425	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—EDN1—asthma	4.86e-07	0.000422	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—CCL5—asthma	4.82e-07	0.000418	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—ARG2—asthma	4.82e-07	0.000418	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—PLA2G4A—asthma	4.8e-07	0.000417	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—CSF2—asthma	4.75e-07	0.000412	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—IL2—asthma	4.68e-07	0.000406	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—SMAD3—asthma	4.62e-07	0.000401	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—NQO1—asthma	4.57e-07	0.000397	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—ADCY2—asthma	4.47e-07	0.000388	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—CXCL8—asthma	4.44e-07	0.000386	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—asthma	4.43e-07	0.000385	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—PPP2CA—asthma	4.42e-07	0.000384	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—GSTP1—asthma	4.4e-07	0.000382	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—CCR5—asthma	4.34e-07	0.000377	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—HMOX1—asthma	4.34e-07	0.000377	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—ITPR1—asthma	4.33e-07	0.000376	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—CAT—asthma	4.28e-07	0.000372	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—IL2RA—asthma	4.28e-07	0.000372	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—IL2—asthma	4.25e-07	0.000369	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—C3—asthma	4.24e-07	0.000368	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—PDGFB—asthma	4.13e-07	0.000359	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—PLA2G4A—asthma	4.04e-07	0.000351	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—GSTM1—asthma	4.04e-07	0.000351	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—ALOX15—asthma	3.99e-07	0.000346	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—ALOX5AP—asthma	3.99e-07	0.000346	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—POMC—asthma	3.95e-07	0.000343	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—LEP—asthma	3.95e-07	0.000343	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—asthma	3.87e-07	0.000336	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—GSTP1—asthma	3.81e-07	0.000331	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—CHAT—asthma	3.81e-07	0.00033	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—HMOX1—asthma	3.76e-07	0.000326	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—ITPR1—asthma	3.75e-07	0.000326	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—FN1—asthma	3.73e-07	0.000323	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—PPP2CA—asthma	3.72e-07	0.000323	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—CAT—asthma	3.71e-07	0.000322	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—ALB—asthma	3.61e-07	0.000313	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—PLA2G4A—asthma	3.5e-07	0.000304	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—GSTM1—asthma	3.5e-07	0.000304	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—NOS3—asthma	3.45e-07	0.000299	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—POMC—asthma	3.39e-07	0.000295	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—ALOX5—asthma	3.39e-07	0.000295	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—CCL2—asthma	3.32e-07	0.000288	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—IL6R—asthma	3.31e-07	0.000287	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—EGFR—asthma	3.25e-07	0.000282	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—CARM1—asthma	3.24e-07	0.000281	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—PPP2CA—asthma	3.23e-07	0.00028	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—DCN—asthma	3.19e-07	0.000277	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—PTGS2—asthma	3.15e-07	0.000274	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—ALDH2—asthma	3.1e-07	0.000269	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—SERPINE1—asthma	3.1e-07	0.000269	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—RHOA—asthma	2.99e-07	0.00026	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—NOS3—asthma	2.96e-07	0.000257	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—GSTT1—asthma	2.95e-07	0.000256	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—POMC—asthma	2.86e-07	0.000248	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—PTEN—asthma	2.75e-07	0.000239	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—CXCL8—asthma	2.63e-07	0.000228	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—ALB—asthma	2.61e-07	0.000226	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—IL2—asthma	2.51e-07	0.000218	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—IL6—asthma	2.5e-07	0.000217	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—NOS3—asthma	2.49e-07	0.000216	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—POMC—asthma	2.48e-07	0.000215	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—NQO1—asthma	2.45e-07	0.000213	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—ADCY2—asthma	2.4e-07	0.000208	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—MMP9—asthma	2.37e-07	0.000206	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—PTEN—asthma	2.36e-07	0.000205	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—PTGS2—asthma	2.28e-07	0.000198	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—ALB—asthma	2.26e-07	0.000196	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—NOS3—asthma	2.16e-07	0.000187	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—VEGFA—asthma	2.13e-07	0.000185	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—STAT3—asthma	2.11e-07	0.000183	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—GSTP1—asthma	2.05e-07	0.000178	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—HMOX1—asthma	2.02e-07	0.000175	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—ITPR1—asthma	2.01e-07	0.000175	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—CAT—asthma	1.99e-07	0.000173	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—PTEN—asthma	1.99e-07	0.000173	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—PTGS2—asthma	1.97e-07	0.000171	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—TGFB1—asthma	1.96e-07	0.00017	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—EGFR—asthma	1.92e-07	0.000167	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—PLA2G4A—asthma	1.88e-07	0.000163	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—GSTM1—asthma	1.88e-07	0.000163	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—PPP2CA—asthma	1.73e-07	0.00015	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—PTEN—asthma	1.72e-07	0.00015	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—IL6—asthma	1.47e-07	0.000128	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—POMC—asthma	1.33e-07	0.000115	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—ALB—asthma	1.21e-07	0.000105	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—NOS3—asthma	1.16e-07	0.000101	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—PTGS2—asthma	1.06e-07	9.2e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—PTEN—asthma	9.24e-08	8.02e-05	CbGpPWpGaD
